Stay updated on Margetuximab Combo in Chinese HER2+ MBC Clinical Trial
Sign up to get notified when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.

Latest updates to the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.2 was added to the Study Record Versions, and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check41 days agoChange DetectedA new revision (v3.5.0) was added to the record history, and the previous revision (v3.4.3) was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision history updated to v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded Revision: v3.4.2 to the Study Record Versions. Removed the older funding-status notice and Revision: v3.4.1.SummaryDifference0.9%

- Check84 days agoChange DetectedAdded a government funding notice and a new revision tag (v3.4.1) to the Record History; the previous revision (v3.4.0) was removed.SummaryDifference0.9%

- Check91 days agoChange DetectedUI updates include showing the glossary, color-coded additions and deletions in the history, and a new revision label (Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to Margetuximab Combo in Chinese HER2+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.